Vitamin D is associated with atheroprotective high-density lipoprotein profile in postmenopausal women

Journal of Clinical Lipidology

Volumn 4, Issue 2, 2010, Pages 113-119

  Kazlauskaite, Rasa ^a   Powell, Lynda H ^a   Mandapakala, Chaitanya ^a   Cursio, John F ^a   Avery, Elizabeth F ^a   Calvin, James ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; ERGOCALCIFEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; VITAMIN D;

ABDOMINAL FAT; ADULT; ARTICLE; ATHEROSCLEROSIS; BODY FAT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART PROTECTION; HUMAN; LIPID COMPOSITION; PARTICLE SIZE; POSTMENOPAUSE; PRIORITY JOURNAL; RACE DIFFERENCE; SEASONAL VARIATION; VITAMIN BLOOD LEVEL;

25-HYDROXYVITAMIN D 2; ABDOMINAL FAT; ADIPOSITY; ATHEROSCLEROSIS; CALCIFEDIOL; CHOLESTEROL, HDL; FEMALE; HUMANS; LIPOPROTEINS, HDL; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MENOPAUSE; MIDDLE AGED; PARTICLE SIZE; VITAMIN D;

EID: 77949965092     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.01.006     Document Type: Article

References (30)

1. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117 (2008) 503-511
2. Wilson P.W., Garrison R.J., Castelli W.P., Feinleib M., McNamara P.M., and Kannel W.B. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols. Am J Cardiol 46 (1980) 649-654
3. Dobnig H., Pilz S., Scharnagl H., et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 168 (2008) 1340-1349
4. Reis J.P., von Muhlen D., Miller III E.R., Michos E.D., and Appel L.J. Vitamin D status and cardiometabolic risk factors in the united states adolescent population. Pediatrics 124 (2009) e371-e379
5. Shea M.K., Benjamin E.J., Dupuis J., et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr 63 (2007) 458-464
6. El Harchaoui K., Arsenault B.J., Franssen R., et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med 150 (2009) 84-93
7. Kannel W.B., Hjortland M.C., McNamara P.M., and Gordon T. Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 85 (1976) 447-452
8. Wortsman J., Matsuoka L.Y., Chen T.C., Lu Z., and Holick M.F. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72 (2000) 690-693
9. Young K.A., Engelman C.D., Langefeld C.D., et al. Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 94 (2009) 3306-3313
10. Cheng S., Massaro J.M., Fox C.S., et al. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes 59 (2010) 242-248
11. Sam S., Haffner S., Davidson M.H., et al. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes. Diabetes 57 (2008) 2022-2027
12. Pascot A., Lemieux S., Lemieux I., et al. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care 22 (1999) 1471-1478
13. Janssen I, Powell LH, Kazlauskaite R, Dugan SA. Testosterone and visceral fat in midlife women: The Study of Women's Health Across the Nation (SWAN) FatPatterning Study. Obesity. [In Press].
14. National Health and Nutrition Examination Survey physician's examination procedures manual. 1999 & 2000. Available at: http://www.cdc.gov/nchs/data/nhanes/pe.pdf. Accessed February 4, 2010.
15. Otvos J. Measurement of triglyceride-rich lipoproteins by nuclear magnetic resonance spectroscopy. Clin Cardiol 22 S2 (1999) II-21-II-27
16. Engelman C.D., Fingerlin T.E., Langefeld C.D., et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J Clin Endocrinol Metab 93 (2008) 3381-3388
17. DeNino W.F., Tchernof A., Dionne I.J., et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 24 (2001) 925-932
18. Hernan M.A., Hernandez-Diaz S., and Robins J.M. A structural approach to selection bias. Epidemiology 15 (2004) 615-625
19. Ockene I.S., Chiriboga D.E., Stanek III E.J., et al. Seasonal variation in serum cholesterol levels: treatment implications and possible mechanisms. Arch Intern Med 164 (2004) 863-870
20. Scragg R., Sowers M., and Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20 (2007) 713-719
21. Rye K.-A., Bursill C.A., Lambert G., Tabet F., and Barter P.J. The metabolism and anti-atherogenic properties of HDL. J. Lipid Res 50 Suppl (2009) S195-S200
22. Reis J.P., von Mühlen D., Kritz-Silverstein D., Wingard D.L., and Barrett-Connor E. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 30 (2007) 1549-1555
23. Reis J.P., von Muhlen D., and Miller III E.R. Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol 159 (2008) 41-48
24. Maki K.C., Rubin M.R., Wong L.G., et al. Serum 25-hydroxyvitamin D is independently associated with high-density lipoprotein cholesterol and the metabolic syndrome in men and women. J Clin Lipidol 3 (2009) 289-296
25. Auwerx J., Bouillon R., and Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 12 (1992) 671-674
26. Hypponen E., and Power C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 29 (2006) 2244-2246
27. Matsuura F., Wang N., Chen W., Jiang X.-C., and Tall A.R. HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest 116 (2006) 1435-1442
28. Mathieu P., Poirier P., Pibarot P., Lemieux I., and Despres J.-P. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 53 (2009) 577-584
29. Grimes D.S. Are statins analogues of vitamin D?. Lancet 368 (2006) 83-86
30. Pérez-Castrillón J.L., Vega G., Abad L., Sanz A., Chaves J., Hernandez G., and Dueñas A. Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 99 (2007) 903-905